Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 1367-1374, 2003; 10.1373/49.8.1367
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carmel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carmel, R.
Related Collections
Right arrow Nutrition
Right arrow Proteomics and Protein Markers
Right arrow Hematology
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2003;49:1367-1374.)
© 2003 American Association for Clinical Chemistry, Inc.


Hematology

Mild Transcobalamin I (Haptocorrin) Deficiency and Low Serum Cobalamin Concentrations

Ralph Carmel1

1 Departments of Medicine, New York Methodist Hospital, Brooklyn, NY 11215, and Weill Medical College of Cornell University, New York, NY 10021.

aAddress for correspondence: NY Methodist Hospital, 506 Sixth St., Brooklyn, NY 11215; fax 718-780-3259; e-mail rac9001{at}nyp.org.

Background: Low cobalamin concentrations are common, but their causes are often unknown. Transcobalamin I/haptocorrin (TC I/HC) deficiency, viewed as a rare cause, has not been examined systematically in patients with unexplained low serum cobalamin.

Methods: Total TC I/HC was measured by RIA in three subgroups of 367, 160, and 38 patients with different categories of low cobalamin concentrations and three comparison subgroups of 112, 281, and 119 individuals with cobalamin concentrations within the reference interval. Additional studies, including family studies, were done in selected patients found to have low TC I/HC concentrations.

Results: Low TC I/HC concentrations suggestive of mild TC I/HC deficiency occurred in 54 of 367 (15%) patients with low cobalamin identified by clinical laboratories and 24 of 160 (15%) patients whose low cobalamin was unexplained after absorption and metabolic evaluation, but in only 2 of 38 patients with malabsorptive causes of low cobalamin concentrations (5%). The prevalence was only 3% (8 of 281 plasma samples) to 5% (6 of 112 sera) in patients with cobalamin concentrations within the reference interval and 3% (4 of 119) in healthy volunteers. Three patients with low cobalamin (0.6%) had severe TC I/HC deficiency with undetectable TC I/HC. Presumptive heterozygotes for severe TC I/HC deficiency in two families had the findings of mild TC I/HC deficiency; mild deficiency was also found in at least three of seven studied families of patients with mild TC I/HC deficiency.

Conclusions: Mild TC I/HC deficiency is frequently associated with low cobalamin, is often familial, and its biochemical phenotype appears identical to the heterozygous state of severe TC I/HC deficiency. Severe TC I/HC deficiency also appears to be more common than suspected. Both diagnoses should be considered in all patients with unexplained low serum cobalamin.




The following articles in journals at HighWire Press have cited this article:


Home page
Age AgeingHome page
S. Loikas, P. Koskinen, K. Irjala, M. Lopponen, R. Isoaho, S.-L. Kivela, and T.-T. Pelliniemi
Vitamin B12 deficiency in the aged: a population-based study
Age Ageing, March 1, 2007; 36(2): 177 - 183.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Carmel
Haptocorrin (Transcobalamin I) and Cobalamin Deficiencies
Clin. Chem., February 1, 2007; 53(2): 367 - 368.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
A. L. Morkbak, A.-M. Hvas, Z. Lloyd-Wright, T. A.B. Sanders, O. Bleie, H. Refsum, O. K. Nygaard, and E. Nexo
Effect of Vitamin B12 Treatment on Haptocorrin
Clin. Chem., June 1, 2006; 52(6): 1104 - 1111.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
R. Carmel, R. Green, D. S. Rosenblatt, and D. Watkins
Update on Cobalamin, Folate, and Homocysteine
Hematology, January 1, 2003; 2003(1): 62 - 81.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.